Sinbiosys and Bacman-HERO: How Innovative Ventures and New Opportunities Take Shape
Two examples from the University of Bologna’s entrepreneurial ecosystem, which today includes 62 accredited companies spanning spin-offs and student startups
Two examples from the University of Bologna’s entrepreneurial ecosystem, which today includes 62 accredited companies spanning spin-offs and student startups
From renewables to carbon capture and storage: where do we stand with the energy transition in a world cyclically marked by geopolitical crises? UniboMagazine discussed it with Professor Ezio Mesini
The definition of what we see depends, at least in part, on the speed at which our brain takes its internal “photographs” of the outside world. When the frequency of alpha waves speeds up, perceptual sensitivity increases
A new invisible marking technology aims to make plastic recycling more efficient and competitive. ELISET, a European project worth €2.36 million, is bringing to market a solution developed from research initiated at the University of Bologna and later advanced through the spin-off Sinbiosys
Produced by five PhD students from the University of Bologna’s International PhD College, the podcast examines artificial intelligence from multiple perspectives and reflects on its role in politics, science and everyday life
The University of Bologna deep-tech spin-off is set to validate a technology in space that is recognised as a strategic priority for Europe
Thanks to the synergy between chemistry and aerospace engineering, the compact analytical device is ready for the first microgravity experiments with astronaut Sophie Adenot
New data from NASA’s Juno mission and the Hubble Space Telescope have enabled scientists to determine the planet’s shape with an uncertainty of just 0.4 kilometres: the gas giant’s radius is 8 kilometres smaller than previous estimates suggested
Seven European partners - including universities and research centres - will collaborate to develop low-energy digital systems through reversible computing
Signal-free junctions navigated seamlessly by vehicles that communicate with one another: the demonstration coordinated by the University of Bologna has won an award within the framework of the PNRR-funded Restart programme
Successfully tested in animal models, a new-generation drug has achieved complete disease regression in models of neuroblastoma and rhabdomyosarcoma, as well as colon cancer. The key lies in antibody–drug conjugates, which can recognise tumour cells and target them with a chemotherapy molecule designed to act selectively